In a preclinical study, lung cancer–induced osteoclastogenesis in vitro was associated with the upregulation of IL-6 and TNF-α and consequent activation of the AMPK/mTOR signaling pathway [38]. This evidence concerns the gene IL6 and lung carcinoma.